OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nano Proteolysis Targeting Chimeras (PROTACs) with Anti‐Hook Effect for Tumor Therapy
Ni‐Yuan Zhang, Da‐Yong Hou, Xingjie Hu, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 37
Closed Access | Times Cited: 39
Ni‐Yuan Zhang, Da‐Yong Hou, Xingjie Hu, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 37
Closed Access | Times Cited: 39
Showing 1-25 of 39 citing articles:
Nano-PROTACs: state of the art and perspectives
Jie Zhong, Ruiqi Zhao, Yuji Wang, et al.
Nanoscale (2024) Vol. 16, Iss. 9, pp. 4378-4391
Closed Access | Times Cited: 19
Jie Zhong, Ruiqi Zhao, Yuji Wang, et al.
Nanoscale (2024) Vol. 16, Iss. 9, pp. 4378-4391
Closed Access | Times Cited: 19
Proteolysis Targeting Chimera Degraders of the METTL3–14 m6A-RNA Methyltransferase
Francesco Errani, Annalisa Invernizzi, Marcin Herok, et al.
JACS Au (2024) Vol. 4, Iss. 2, pp. 713-729
Open Access | Times Cited: 15
Francesco Errani, Annalisa Invernizzi, Marcin Herok, et al.
JACS Au (2024) Vol. 4, Iss. 2, pp. 713-729
Open Access | Times Cited: 15
Restraining the power of Proteolysis Targeting Chimeras in the cage: A necessary and important refinement for therapeutic safety
Renshuai Zhang, Songbo Xie, Jie Ran, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 5
Closed Access | Times Cited: 10
Renshuai Zhang, Songbo Xie, Jie Ran, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 5
Closed Access | Times Cited: 10
Liposomal STAT3-Degrading PROTAC Prodrugs Promote Anti-Hepatocellular Carcinoma Immunity via Chemically Reprogramming Cancer Stem Cells
Xuan Wang, Youbo Zhao, Xin Li, et al.
Nano Letters (2024)
Closed Access | Times Cited: 10
Xuan Wang, Youbo Zhao, Xin Li, et al.
Nano Letters (2024)
Closed Access | Times Cited: 10
Cathepsin B Responsive Peptide–Purpurin Conjugates Assembly-Initiated in Situ Self-Aggregation for Cancer Sonotheranostics
Qixuan Dai, Lisi Xie, En Ren, et al.
Nano Letters (2024) Vol. 24, Iss. 3, pp. 950-957
Closed Access | Times Cited: 9
Qixuan Dai, Lisi Xie, En Ren, et al.
Nano Letters (2024) Vol. 24, Iss. 3, pp. 950-957
Closed Access | Times Cited: 9
Intracellular Chemical Reaction‐Induced Self‐Assembly for the Construction of Artificial Architecture and Its Functions
Sangpil Kim, Gaeun Park, Dohyun Kim, et al.
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 9
Sangpil Kim, Gaeun Park, Dohyun Kim, et al.
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 9
Rational strategies for improving the efficiency of design and discovery of nanomedicines
Xiaoting Shan, Ying Cai, Binyu Zhu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Xiaoting Shan, Ying Cai, Binyu Zhu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Application of PROTACs in target identification and validation
Yang Liu, Jing Liang, Rui Zhu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 6
Yang Liu, Jing Liang, Rui Zhu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 6
Copper‐Induced Supramolecular Peptide Assemblies for Multi‐pathway Cell Death and Tumor Inhibition
Xiangyang Zhang, Buyue Zhang, Ying Zhang, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 34
Closed Access | Times Cited: 6
Xiangyang Zhang, Buyue Zhang, Ying Zhang, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 34
Closed Access | Times Cited: 6
Proteolysis-targeting drug delivery system (ProDDS): integrating targeted protein degradation concepts into formulation design
Yu Chen, Fengyuan Liu, Samira Pal, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 19, pp. 9582-9608
Closed Access | Times Cited: 6
Yu Chen, Fengyuan Liu, Samira Pal, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 19, pp. 9582-9608
Closed Access | Times Cited: 6
Progress of proteolysis-targeting chimeras (PROTACs) delivery system in tumor treatment
Lianlian Fan, Weifang Tong, Anhui Wei, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133680-133680
Open Access | Times Cited: 5
Lianlian Fan, Weifang Tong, Anhui Wei, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133680-133680
Open Access | Times Cited: 5
Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy
Yue Song, Qing‐Qing Dong, Yi-Ke Ni, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 5739-5761
Open Access | Times Cited: 4
Yue Song, Qing‐Qing Dong, Yi-Ke Ni, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 5739-5761
Open Access | Times Cited: 4
Biomimetic Nanomaterials Based on Peptide In Situ Self‐Assembly for Immunotherapy Applications
Zhuan Wen, Zhang‐Zhi Song, M. S. Cai, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2025) Vol. 17, Iss. 1
Closed Access
Zhuan Wen, Zhang‐Zhi Song, M. S. Cai, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2025) Vol. 17, Iss. 1
Closed Access
Noncanonical Amino Acids Dictate Peptide Assembly in Living Cells
Xin Liu, Binbin Hu, Zhilin Yu
Accounts of Chemical Research (2025)
Closed Access
Xin Liu, Binbin Hu, Zhilin Yu
Accounts of Chemical Research (2025)
Closed Access
Self-Reporting Ratiometric AIEgen-Peptide Nanoprobes for Activatable Chemotherapy and Noninvasive Imaging of Therapeutic Outcomes
Shicheng Pei, Z. L. Liu, Qishu Jiao, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Shicheng Pei, Z. L. Liu, Qishu Jiao, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Cancer Specific CAIX‐Targeting Supramolecular Lysosome‐Targeting Chimeras (Supra‐LYTAC) for Targeted Protein Degradation
Do‐Hyun Kim, Gyeongseok Yang, Chaelyeong Lim, et al.
Advanced Science (2025)
Open Access
Do‐Hyun Kim, Gyeongseok Yang, Chaelyeong Lim, et al.
Advanced Science (2025)
Open Access
Integrating Proteolysis‐Targeting Chimeras (PROTACs) with Delivery Systems for More Efficient and Precise Targeted Protein Degradation
Jiachan Lin, Zirui Chen, Dan Zhang, et al.
Macromolecular Rapid Communications (2025)
Closed Access
Jiachan Lin, Zirui Chen, Dan Zhang, et al.
Macromolecular Rapid Communications (2025)
Closed Access
Advancements in delivery Systems for Proteolysis-Targeting Chimeras (PROTACs): Overcoming challenges and expanding biomedical applications
Yawei Yu, Weitong Hu, Yihua Xu, et al.
Journal of Controlled Release (2025), pp. 113719-113719
Closed Access
Yawei Yu, Weitong Hu, Yihua Xu, et al.
Journal of Controlled Release (2025), pp. 113719-113719
Closed Access
CRBN‐PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access | Times Cited: 3
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access | Times Cited: 3
Non-invasive in vivo monitoring of PROTAC-mediated protein degradation using an environment-sensitive reporter
Tao Li, Qingyu Zong, Dong He, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Tao Li, Qingyu Zong, Dong He, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Copper‐Induced Supramolecular Peptide Assemblies for Multi‐pathway Cell Death and Tumor Inhibition
Xiangyang Zhang, Buyue Zhang, Ying Zhang, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 34
Closed Access | Times Cited: 2
Xiangyang Zhang, Buyue Zhang, Ying Zhang, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 34
Closed Access | Times Cited: 2
Adaptive enzyme-responsive self-assembling multivalent apelin ligands for targeted myocardial infarction therapy
Jiejing Li, Xudong Song, Xu Liao, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 571-586
Closed Access | Times Cited: 2
Jiejing Li, Xudong Song, Xu Liao, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 571-586
Closed Access | Times Cited: 2
PROTAC degraders of the METTL3-14 m6A-RNA methyltransferase
Francesco Errani, Annalisa Invernizzi, Marcin Herok, et al.
(2024)
Open Access | Times Cited: 1
Francesco Errani, Annalisa Invernizzi, Marcin Herok, et al.
(2024)
Open Access | Times Cited: 1
PROTACs in Ovarian Cancer: Current Advancements and Future Perspectives
Makenzie Vorderbruggen, Carlos A. Velázquez‐Martínez, Amarnath Natarajan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5067-5067
Open Access | Times Cited: 1
Makenzie Vorderbruggen, Carlos A. Velázquez‐Martínez, Amarnath Natarajan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5067-5067
Open Access | Times Cited: 1
Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors
Qiangfeng Wang, Yumeng Zhu, Junping Pei
Future Medicinal Chemistry (2024) Vol. 16, Iss. 18, pp. 1923-1944
Closed Access | Times Cited: 1
Qiangfeng Wang, Yumeng Zhu, Junping Pei
Future Medicinal Chemistry (2024) Vol. 16, Iss. 18, pp. 1923-1944
Closed Access | Times Cited: 1
